HOME > TOP STORIES
TOP STORIES
-
REGULATORY FY2019 Revision Should Cover Only “Half a Year’s Worth” of Price Tweaks, MHLW Insurance Chief Says for Clarification
September 3, 2018
-
REGULATORY April 2019 Price Cut Wouldn’t Fit the Purpose of Tax Tweak: MHLW Insurance Chief
August 31, 2018
-
BUSINESS With Bullish Maviret, AbbVie Aims for Double-Digit Growth to Join Top 20 in 2018
August 30, 2018
-
BUSINESS Imfinzi, Gazyva Now Available in Japan
August 30, 2018
-
REGULATORY MHLW Discussing Use of Data from “Specified Clinical Research” in Application Dossiers, Will Issue Preliminary Conclusions by March
August 29, 2018
-
BUSINESS Gilead Japan Looks to End HIV Pacts with JT as It Seeks Long-Term Growth: Chief
August 28, 2018
-
BUSINESS Gilead, JT Start Talks on Terminating Japan HIV Pacts
August 27, 2018
-
REGULATORY Japan Eyes State Funds to Boost Sakigake Review Staffers: FY2019 Budget Request
August 27, 2018
-
REGULATORY MHLW to Expand MID-NET and Coordinate with Other Databases and Registries to Improve Safety Measures: Official
August 27, 2018
-
ORGANIZATION Regulatory Science Society Says “No” to Off-Label Info Supply by Drug Reps Conditionally OK’ed in Draft MHLW GLs
August 24, 2018
-
REGULATORY Chuikyo Discusses ICER Evaluations for Drugs with Multiple Indications
August 23, 2018
-
REGULATORY Just Months after Big Re-Pricing, Opdivo Faces 37.5% Price Slash on Dose Change
August 22, 2018
-
BUSINESS Mitsubishi Tanabe Going Digital to Shed Drug Discovery and Sales Outlays: President
August 21, 2018
-
BUSINESS I/O in Lung Cancer - 2: After MYSTIC Flop, AstraZeneca’s Imfinzi Makes Comeback with Stage III NSCLC Nod
August 20, 2018
-
REGULATORY MHLW Revving Up Biosimilar Drive with Educational Workshop for Healthcare Pros
August 17, 2018
-
REGULATORY Japan Approves Nesp “Biosame,” Eyes Riveted on December Listing
August 16, 2018
-
BUSINESS I/O in Lung Cancer - 1: US Merck Sweeping Frontline NSCLC Space with Keytruda
August 10, 2018
-
BUSINESS As Rituxan Biosimilar Enjoys Solid Start, Sandoz Japan Chief Says It’s Important to Be First to Market
August 9, 2018
-
BUSINESS Otsuka’s Half-Year Pharma Sales Up 4.1% on Global Brands
August 9, 2018
-
TRENDS Strong April-June Sales Show Market Shift to SGLT2/DPP-4 Combos
August 8, 2018
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
